W
Won Ki Kang
Researcher at Samsung Medical Center
Publications - 385
Citations - 18420
Won Ki Kang is an academic researcher from Samsung Medical Center. The author has contributed to research in topics: Cancer & Capecitabine. The author has an hindex of 59, co-authored 368 publications receiving 14746 citations. Previous affiliations of Won Ki Kang include Sungkyunkwan University & Samsung.
Papers
More filters
Journal ArticleDOI
Multicenter phase III trial of adjuvant chemoradiotherapy in stomach tumors 2 (ARTIST 2).
Se Hoon Park,Su Jin Lee,Seung Tae Kim,Jeeyun Lee,Joon Oh Park,Young Suk Park,Ho Yeong Lim,Won Ki Kang +7 more
TL;DR: Compared disease-free survival (DFS) in Korean patients with D2-resected GC is reported and patients with node-positive disease and intestinal type GC may have benefit with the addition of radiotherapy to adjuvant chemotherapy.
Journal ArticleDOI
Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study
Yeul Hong Kim,Hyun Cheol Chung,Won Ki Kang,Sook Ryun Park,Chul Soo Kim,Tae Yue Kim,Sang Won Shin,Byung Joo Park,Soo Jin Cha,Yung-Jue Bang +9 more
TL;DR: PemCis has a modest activity and acceptable toxicity profile in patients with AGC and clinical trials with different combinations and dose regimens are, therefore, warranted.
Journal ArticleDOI
Phase II Study of Irinotecan, 5-Fluorouracil and Leucovorin as First-line Therapy for Advanced Colorectal Cancer
Sang Hoon Ji,Young Suk Park,Jeeyun Lee,Do Hyoung Lim,Byeong Bae Park,Keun Woo Park,Jung Hun Kang,Se-Hoon Lee,Joon Oh Park,Kihyun Kim,Won Seog Kim,Chul Won Jung,Young-Hyuck Im,Won Ki Kang,Keunchil Park +14 more
TL;DR: It is concluded that the modified Douillard regimen may be a practical and more tolerable treatment option in patients with advanced colorectal cancer.
Journal ArticleDOI
LAG3 in Solid Tumors as a Potential Novel Immunotherapy Target
Su Jin Lee,Sun-Ju Byeon,Jeeyun Lee,Se Hoon Park,Joon Oh Park,Young Suk Park,Won Ki Kang,Ho Yeong Lim,Kyoung-Mee Kim,Seung Tae Kim +9 more
TL;DR: The results of this prospective immunohistochemical analysis of lymphocyte activation gene 3 (LAG3) for 430 consecutive patients with advanced gastrointestinal, genitourinary, or rare cancers support the need for extended clinical exploration of this target for immunotherapy.
Journal ArticleDOI
Prognostic Impact of Sarcopenia and Radiotherapy in Patients With Advanced Gastric Cancer Treated With Anti-PD-1 Antibody.
Nalee Kim,Jeong Il Yu,Do Hoon Lim,Jeeyun Lee,Seung Tae Kim,Jung Yong Hong,Won Ki Kang,Woo Kyoung Jeong,Kyoung-Mee Kim +8 more
TL;DR: In this paper, the combined effects of sarcopenia and radiotherapy (RT) on outcomes in patients with advanced gastric cancer (AGC) treated with immune-checkpoint blockade (ICB) were explored.